• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.

作者信息

Viana de Andrade Ana Carolina Dias, Brito Érica Andrade, Harris Olga Maria Oiticica, Viana de Andrade Ana Paula Dias, Leite Mateus Freire, Pithon Matheus Melo

机构信息

Department of Health, Southwest Bahia State University - UESB, Jequié, Bahia, Brazil.

出版信息

Int J Dermatol. 2015;54(5):e140-5. doi: 10.1111/ijd.12676. Epub 2014 Sep 10.

DOI:10.1111/ijd.12676
PMID:25208461
Abstract
摘要

相似文献

1
Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon-beta 1a: Case Report.用干扰素-β1a治疗多发性硬化症期间发生系统性结节病和平滑肌瘤：病例报告
Int J Dermatol. 2015;54(5):e140-5. doi: 10.1111/ijd.12676. Epub 2014 Sep 10.
2
Interferon β associated nephropathy in a Multiple Sclerosis patient: A case and review.干扰素β相关性肾病在多发性硬化症患者中的病例及文献复习
Mult Scler Relat Disord. 2016 Sep;9:50-3. doi: 10.1016/j.msard.2016.06.012. Epub 2016 Jun 27.
3
The Case | The young philosopher with multiple sclerosis and proteinuria.病例 | 患有多发性硬化症和蛋白尿的年轻哲学家
Kidney Int. 2016 Apr;89(4):961-3. doi: 10.1016/j.kint.2015.10.013.
4
Sarcoidosis associated with Interferon beta treatment.与β-干扰素治疗相关的结节病
Med Clin (Barc). 2019 Sep 13;153(5):e21-e22. doi: 10.1016/j.medcli.2018.11.021. Epub 2019 Jan 2.
5
Acute liver failure and liver transplantation in a patient with multiple sclerosis treated with interferon beta.一名接受β-干扰素治疗的多发性硬化症患者出现急性肝衰竭及肝移植情况。
Neurol Neurochir Pol. 2015;49(6):451-5. doi: 10.1016/j.pjnns.2015.08.006. Epub 2015 Sep 9.
6
Acute hepatitis secondary to interferon beta-1a in multiple sclerosis.多发性硬化症中继发于β-1a干扰素的急性肝炎。
J Neurol. 2005 Jul;252(7):855-6. doi: 10.1007/s00415-005-0767-2. Epub 2005 Mar 8.
7
Marked hypertriglyceridemia induced by interferon-β1a therapy in a clinically isolated syndrome patient.一名临床孤立综合征患者接受干扰素-β1a治疗后出现显著的高甘油三酯血症。
J Neurol Sci. 2017 Feb 15;373:144-146. doi: 10.1016/j.jns.2016.12.052. Epub 2016 Dec 27.
8
Severe Respiratory Failure Due to Interferon Beta-Related Pulmonary Hypertension.干扰素β相关肺动脉高压所致严重呼吸衰竭
Am J Ther. 2016 Sep-Oct;23(5):e1275-6. doi: 10.1097/MJT.0000000000000348.
9
Vitiligo and multiple sclerosis in a patient treated with interferon beta-1a: a case report.用β-1a干扰素治疗的患者出现白癜风和多发性硬化症：一例报告
Eur J Neurol. 2009 Apr;16(4):e78-9. doi: 10.1111/j.1468-1331.2009.02563.x.
10
Interferon beta retinopathy in a patient with multiple sclerosis.一名多发性硬化症患者的β-干扰素视网膜病变
Can J Ophthalmol. 2009 Oct;44(5):e37. doi: 10.3129/i09-094.

引用本文的文献

1
Atypical adverse events in a real-world study of long-term immunomodulation for multiple sclerosis and neuromyelitis optica spectrum disorder.一项针对多发性硬化症和视神经脊髓炎谱系障碍的长期免疫调节的真实世界研究中的非典型不良事件。
Ther Adv Neurol Disord. 2025 Apr 4;18:17562864251320206. doi: 10.1177/17562864251320206. eCollection 2025.
2
Advance in pathogenesis of sarcoidosis: Triggers and progression.结节病发病机制的进展：触发因素与病情进展
Heliyon. 2024 Mar 8;10(5):e27612. doi: 10.1016/j.heliyon.2024.e27612. eCollection 2024 Mar 15.
3
Adverse side effects of Glatiramer acetate and Interferon beta-1a in patients with multiple sclerosis: A systematic review of case reports.
醋酸格拉替雷和干扰素β-1a治疗多发性硬化症患者的不良副作用：病例报告的系统评价
Curr J Neurol. 2023 Apr 4;22(2):115-136. doi: 10.18502/cjn.v22i2.13340.
4
Interferon-induced sarcoidosis with uveitis as the initial symptom: a case report and review of the literature.以葡萄膜炎为首发症状的干扰素诱导的结节病 1 例报告并文献复习。
J Med Case Rep. 2021 Nov 27;15(1):568. doi: 10.1186/s13256-021-03181-x.
5
Multiple sclerosis and sarcoidosis: A case for coexistence.多发性硬化症与结节病：并存病例报告
Neurol Clin Pract. 2019 Jun;9(3):218-227. doi: 10.1212/CPJ.0000000000000629.